missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Rebastinib, MedChemExpress
Description
Rebastinib (DCC-2036) is an orally active, non-ATP-competitive Bcr-Abl inhibitor for Abl1WT and Abl1T315I with IC50s of 0.8 nM and 4 nM, respectively. Rebastinib also inhibits SRC, KDR, FLT3, and Tie-2, and has low activity to seen towards c-Kit.
Specifications
Specifications
| Chemical Name or Material | Rebastinib |
| CAS | 1020172-07-9 |
| Color | Off-White |
| Purity Grade Notes | Research |
| Molecular Formula | C30H28FN7O3 |
| Quantity | 50 mg |
| Synonym | DCC-2036 |
| Solubility Information | DMSO : 50 mg/mL (90.32 mM; ultrasonic and warming and heat to 80°C) |
| SMILES | CC(C)(C)C1=NN(C(NC(NC2=C(F)C=C(OC3=CC(C(NC)=O)=NC=C3)C=C2)=O)=C1)C4=CC=C5C(C=CC=N5)=C4 |
| Molecular Weight (g/mol) | 553.59 |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?